Hot or Nothing
See My Plan
Woman with long auburn hair in a floral kimono sitting by the water at sunset

Is BPC-157 or TB-500 Safe with Blood Thinners or Aspirin?

Can BPC-157 or TB-500 be safely taken while using prescription blood thinners or daily aspirin?

Reviewed by Taylor Anderson, RN

Aesthetic Registered Nurse

Taylor Anderson is an aesthetic registered nurse and a reviewer for Hot or Nothing.

Updated October 15, 2026

Quick answer

Nobody knows yet whether BPC-157 or TB-500 is safe to take with a blood thinner or a daily aspirin, because the combination has never been tried in people. In rats, BPC-157 pushed back against aspirin and two similar anti-clotting drugs and cut bleeding in rats on heparin or warfarin, so the peptide may work against your medicine. If you take a blood thinner or aspirin, give your clinical team your full medication list and let them decide whether BPC-157 or TB-500 fits your plan.

In this guide

Key takeaways

  • Nobody knows yet whether BPC-157 or TB-500 is safe with a blood thinner or daily aspirin, because no one has tried the combination in people.
  • In rats, BPC-157 pushed back against aspirin, clopidogrel and cilostazol and cut bleeding on heparin or warfarin, which could mean it works against your blood thinner.
  • TB-500 has never been tried with blood thinners, but the natural protein it comes from helps blood clot in mice and in lab tests, and FDA has found no data on people taking the TB-500 fragment.
  • BPC-157 has been tried in people only for knee pain, a painful bladder condition and IV safety, with no side effects reported, and none of those people were on blood thinners or aspirin.
  • An injury or surgery is when bleeding and clotting matter most, so bring every medicine you take, including aspirin, to your clinical team before adding either peptide.

No study in people has tested BPC-157 or TB-500 alongside a blood thinner or daily aspirin, so no one can yet tell you the combination is safe. The animal research points in a direction you should know about. In rats, BPC-157 blunted the effect of aspirin, clopidogrel and cilostazol on platelets, and it reduced bleeding in rats given heparin or warfarin.

Researchers see that as protection from bleeding. If you take a blood thinner to prevent a clot or a stroke, it means something else: a peptide that may work against your medicine.

So don't start either peptide on your own. Give your clinical team every medicine you take, including a daily aspirin, and let them decide whether BPC-157 or TB-500 fits your plan.

What does research show about BPC-157 and blood thinners?

In rats, BPC-157 worked against three platelet-blocking drugs and cut bleeding in rats on heparin or warfarin. Platelets are the small blood cells that plug a cut, and that is where BPC-157's effect showed up.

Rat studies only

Blood thinner or aspirin How the rats got it What happened when BPC-157 was added
Aspirin By stomach, once a day for three days BPC-157 given right after each dose restored one type of platelet clumping that aspirin blocks. Its effect on the other platelet tests was not statistically significant.
Clopidogrel (Plavix) By stomach, once a day for three days BPC-157 given right after each dose counteracted the drug's effect on platelet clumping.
Cilostazol By stomach, once a day for three days BPC-157 given right after each dose counteracted the drug's effect on platelet clumping.
Heparin IV, with a tail cut BPC-157 reduced bleeding and kept platelet counts from dropping.
Warfarin By stomach, with a tail cut BPC-157 reduced bleeding and kept platelet counts from dropping.

The aspirin result is narrower than it first looks. BPC-157 brought back the platelet clumping that aspirin normally blocks in one test, but not across the board, so it was not shown to fully reverse aspirin.

BPC-157 did not change the clotting-factor tests in those rats. The authors think it acts on the platelets directly. In healthy rats not on any blood thinner, BPC-157 by itself did not change normal clotting or platelet values.

If you take a blood thinner or aspirin to prevent a clot, a peptide that may push back against it is a question to answer before you start. Nobody has tested whether this happens in women or whether it would weaken your medicine.

Does TB-500 affect bleeding or clotting?

No one has tested TB-500 itself with blood thinners. The protein it comes from does play a part in clotting. TB-500 is a short fragment of thymosin beta-4, a protein your platelets carry naturally. FDA lists it as "Thymosin beta-4, fragment (LKKTETQ), also known as TB-500."

In mice bred without thymosin beta-4, platelets formed clots poorly, and a tail cut bled about twice as long: 11.6 minutes, against 5.4 minutes in normal mice.

In a lab test using blood from five healthy adults aged 25 to 40, small amounts of thymosin beta-4 made platelets stick about three times as much. Larger amounts brought sticking back to near normal.

Both studies used the whole natural protein, not the TB-500 fragment. FDA says it "has not identified any human exposure data" for products containing the fragment. That means nobody knows how TB-500 behaves alongside a blood thinner, in either direction.

Has BPC-157 been tested in people?

Yes, but only in three small pilot studies, and none included people on blood thinners or aspirin. They covered knee pain, interstitial cystitis (a painful bladder condition) and the safety of giving it by IV.

Those pilot studies reported no side effects. None of them were large, rigorous trials.

FDA says it lacks enough information to know whether compounded BPC-157 would cause harm in people. It flags a possible immune reaction for certain routes of administration (the way a drug gets into your body) and concerns about impurities in the peptide. Ask your clinical team what to watch for.

Why do people take BPC-157 after an injury or surgery?

People want it because, in their own accounts, pain can ease quickly. One man with six years of shoulder pain wrote on Reddit: "By week two, I was going about my day and suddenly realized the shoulder didn't hurt. Just gone. Finished that 40-day run and I'd say about 60–70% of the pain had vanished, though I still had the odd bad morning." That was his result over one 40-day run.

Many people start right after an injury or around surgery. Another Reddit poster wrote that "The extensor tendon for my middle finger and ring finger on the top of my hand were severed" by a tool, with "About a pint of blood lost." He ordered a blend containing BPC-157, TB-500, KPV and GHK-Cu, and later had surgery.

Injuries and surgery are when bleeding and clotting matter most. If you are on a blood thinner or aspirin, that is the moment to bring your clinical team in, not the moment to order a vial on your own. Hot or Nothing's healing and recovery plans include BPC-157, TB-500 and sermorelin, prescribed by our clinical team after they look at what you already take.

What should you tell your clinical team before adding BPC-157 or TB-500?

  • Every blood thinner you take, and why. For example warfarin, heparin, apixaban, rivaroxaban or clopidogrel, and the reason, such as a past clot, atrial fibrillation or a stent.
  • A daily aspirin, with its dose. Mention it even if you bought it over the counter, and list any supplements you take.
  • Any recent injury or planned surgery. That is often when people want these peptides.
  • What to watch for. Ask how they would check on you if a peptide is added.
  • Let them make the call. Your clinical team decides whether BPC-157 or TB-500 belongs in your plan alongside your blood thinner, or whether another recovery option fits you better.

Take the quiz so your clinical team sees your full medication list, including any blood thinner or daily aspirin, and can build a recovery plan for your injury that fits around it.

Ready to make a move?

Answer three questions to see the treatment options that fit your goals.

See My Plan

FAQ

Does BPC-157 thin your blood?

BPC-157 has not been shown to thin blood. In rats on aspirin and other anti-clotting drugs, it did the opposite of a blood thinner: it pushed back against those drugs and cut bleeding. In healthy rats not on any blood thinner, BPC-157 by itself did not change normal clotting or platelet values, and it has not been tested for this in people.

Can BPC-157 cause blood clots?

No one has shown that BPC-157 causes blood clots, but it has not been checked for clot risk in people either. In healthy rats, BPC-157 alone did not change normal clotting or platelet values, and it did not change clotting-factor tests in rats on anti-clotting drugs. The open question is for women who take a blood thinner to prevent a clot, since in rats BPC-157 worked against those medicines, so tell your clinical team before you start.

Can you take BPC-157 with Eliquis or Xarelto?

No one has tried BPC-157 with Eliquis (apixaban) or Xarelto (rivaroxaban), in people or in rats, so nobody can say the combination is safe. The closest evidence comes from rats on heparin or warfarin, where BPC-157 reduced bleeding, which could mean it pushes back against a blood thinner. Give your clinical team your full medication list and the reason you take your blood thinner, and let them decide whether BPC-157 fits your plan.

Is TB-500 safe to take after surgery?

Nobody knows yet how TB-500 behaves after surgery, because FDA has found no data on people taking the TB-500 fragment. The natural protein it comes from helps platelets form clots in mice and lab tests, and surgery is when bleeding and clotting matter most. Hot or Nothing's healing and recovery plans include TB-500, prescribed by our clinical team after they look at what you already take, so tell them about your surgery and any blood thinner or aspirin first.

Keep reading

Sources (5)
  1. Intragastric Application of Aspirin, Clopidogrel, Cilostazol, and BPC 157 in Rats: Platelet Aggregation and Blood Clot - PMC · pmc.ncbi.nlm.nih.gov · captured October 15, 2026
  2. Pentadecapeptide BPC 157 Reduces Bleeding and ... - PMC · pmc.ncbi.nlm.nih.gov · captured October 15, 2026
  3. Thymosin β4 is essential for thrombus formation by controlling the G-actin/F-actin equilibrium in platelets - PMC · pmc.ncbi.nlm.nih.gov · captured October 15, 2026
  4. Whole blood, flow-chamber studies in real-time indicate a biphasic role for thymosin β-4 in platelet adhesion · sciencedirect.com · captured October 15, 2026
  5. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA · fda.gov · captured October 15, 2026